Gelteq

Our Co-Founders, CEO Mr. Nathan Givoni and Executive Chairman Mr. Simon Szewach, will be participating in the Benchmark Company 13th Annual Discovery Investor Conference being held on Wednesday, December 11, 2024, at the New York Athletic Club in New York City. Learn more in our press release: https://lnkd.in/eKZ_gXUn #Gelteq $GELS #GelPlatform

Gelteq announces today that its largest U.S. customer has increased its initial order to meet growing market demand. Healthy Extracts Inc has increased its initial purchase order of Gelteq collagen and Mynus sugar blocker gels by 50%, citing the high demand and popularity of the products. This growing partnership supports Gelteq’s strategic push into the U.S. market. Production of Healthy Extracts’ order is underway, with shipment expected in January 2025. Read more in the full press release: https://lnkd.in/eZNhV8XD #Gelteq $GELS #HealthyExtracts #GelPlatform

Happy Thanksgiving! Wishing a joyful Thanksgiving holiday to our clients, friends, and staff in the United States today. #GELS #Gelteq #GelFormulations #GelTechnology #Thanksgiving

Gelteq announced today 400,000 units entered into production in November 2024. These units will fulfill orders made for clients in the U.S and Australia. Delivery is expected in January 2025 for sales across the two countries as well as in the UAE and in Asia. The production run includes Gelteq nutraceutical products in the areas of sports, anti-aging, and weight loss. Read more in our latest press release: https://lnkd.in/e6Yx2ewP $GELS #Gelteq #GelTechnology

Gelteq announced this week the appointment of Adam Bendell as President of U.S. Operations to scale domestic business and operations. Adam is an accomplished corporate strategist with nearly a decade of experience driving growth and transformational change for global companies, retail brands, and government organizations. Read more in our latest press release: https://lnkd.in/eXEU3yqa $GELS #Gelteq #GelTechnology

Gelteq is proud to share that the company is now publicly listed on the Nasdaq under the ticker symbol $GELS. This would not have been possible without the hard work and dedication of our two co-founders Nathan Givoni and Simon Szewach, our incredible Gelteq team, as well as countless others who believe in a more accessible drug delivery system. We're excited for this next stage in our company's growth as a publicly traded company and look forward to sharing our vision for a gel-based medicine and nutrient delivery platform with the investing public. Closing press release: https://lnkd.in/ea_fwsdi #Gelteq #GelPlatform #Public #Nasdaq $GELS

Gelteq's Cofounders Nathan Givoni and Simon Szewach recently joined the The Good Men Project to talk about the accessibility benefits of our proprietary gel-based platform. Thanks for having us! Read more in the full article here: https://lnkd.in/ex-FjTat #Gelteq #GelPlatform #Accessibility

CEO Nathan Givoni recently joined Drug Development & Delivery to discuss the evolution of drug delivery methods with a specific focus on Gelteq's gel-based platform to expand accessibility. Read more: https://lnkd.in/ep_EVsup. #Gelteq #DrugDelivery #Breakthrough

CEO Nathan Givoni recently joined Valiant CEO Magazine for an interview to discuss the need for resilient leadership when starting a pharmaceutical technology business like Gelteq. Read more below: https://lnkd.in/gCpbZpyU #Gelteq #CEO #Leadership

In case you missed it, Gelteq announced last month a partnership with Monash Human Power! We are proud to be fueling Monash Human Power in its pursuit of new speed records with our innovative gel technology. Check out this great video of Monash Human Power's incredible story and two-wheeled, record-holding, human-powered vehicle. #Gelteq #Innovation #Partnerships #Research #ICYMI